Dayton Clinical Oncology Program

Dayton, Ohio 45459

0 studies enrolling now · 11 studies all time

What they study most

Breast Cancer, Breast Carcinoma, Breast Neoplasms, Cancer Survivor, Diffuse Large-Cell Lymphoma, HER2-negative Breast Cancer, Insomnia, Malignant Neoplasm, Multiple Myeloma, NSCLC, Non Small Cell Lung Carcinoma, Non-small-cell Lung Cancer

Studies at this site

• Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer — Completed
• A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin — Completed
• Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors — Completed
• Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling — Status unconfirmed
• A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. — Stopped early
• Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer — Completed
• Non-small Cell Lung Cancer Study US75 (Z-PACT) — Completed
• Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma — Completed
• Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer — Completed
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone — Completed
• Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy — Completed